Health Catalyst Q1 2024 Adj EPS $0.05 Beats $0.03 Estimate, Sales $74.723M Miss $74.802M Estimate
Health Catalyst Q1 2024 Adj EPS $0.05 Beats $0.03 Estimate, Sales $74.723M Miss $74.802M Estimate
Health Catalyst 2024年第一季度调整后的每股收益为0.05美元，超过0.03美元的预期，销售额为7,472.3万美元，低于7,4802万美元的预期
Health Catalyst (NASDAQ:HCAT) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $0.03 by 66.67 percent. This is unchanged from the same period last year. The company reported quarterly sales of $74.723 million which missed the analyst consensus estimate of $74.802 million by 0.10 percent. This is a 1.16 percent increase over sales of $73.868 million the same period last year.
Health Catalyst（纳斯达克股票代码：HCAT）公布的季度收益为每股0.05美元，比分析师共识估计的0.03美元高出66.67％。这与去年同期相比没有变化。该公司公布的季度销售额为7,472.3万美元，比分析师普遍预期的7,480.2万美元低0.10％。这比去年同期的7386.8万美元的销售额增长了1.16％。